Covered recipient · General Payments record
YDANIA SANTACLARA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$2,205.87
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,894.50 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $1,112.68 | 23 |
| Acerta Pharma LLC | $469.57 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.58 | 1 |
| ABBVIE INC. | $98.96 | 1 |
| Merck Sharp & Dohme Corporation | $35.00 | 1 |
| Novo Nordisk AS | $19.57 | 1 |
| Kowa Pharmaceuticals America, Inc. | $18.47 | 1 |
| Lilly USA, LLC | $15.67 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $98.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108143226 | CMS |
| Amgen Inc. | $15.28 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675145 | CMS |
| Amgen Inc. | $21.13 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675147 | CMS |
| Amgen Inc. | $109.90 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117374253 | CMS |
| Amgen Inc. | $109.90 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117374257 | CMS |
| Amgen Inc. | $128.37 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675175 | CMS |
| Amgen Inc. | $128.37 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675177 | CMS |
| Amgen Inc. | $21.25 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675149 | CMS |
| Amgen Inc. | $11.81 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675151 | CMS |
| Amgen Inc. | $129.28 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117374255 | CMS |
| Amgen Inc. | $2.82 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675153 | CMS |
| Amgen Inc. | $2.64 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675155 | CMS |
| Amgen Inc. | $8.99 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675157 | CMS |
| Amgen Inc. | $132.76 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117374259 | CMS |
| Amgen Inc. | $5.87 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675159 | CMS |
| Amgen Inc. | $9.24 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675161 | CMS |
| Amgen Inc. | $8.13 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675163 | CMS |
| Amgen Inc. | $119.70 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675179 | CMS |
| Amgen Inc. | $119.70 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675181 | CMS |
| Amgen Inc. | $9.30 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675165 | CMS |
| Amgen Inc. | $2.37 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675167 | CMS |
| Amgen Inc. | $5.29 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675169 | CMS |
| Amgen Inc. | $2.40 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675171 | CMS |
| Amgen Inc. | $8.18 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117675173 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.99 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105808256 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.81 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105733447 | CMS |
| AstraZeneca Pharmaceuticals LP | $91.29 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105497165 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.27 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104467298 | CMS |
| AstraZeneca Pharmaceuticals LP | $107.21 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105256144 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.58 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117974209 | CMS |
| Kowa Pharmaceuticals America, Inc. | $18.47 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113474611 | CMS |
| Lilly USA, LLC | $15.67 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135977996 | CMS |
| Merck Sharp & Dohme LLC | $35.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141614884 | CMS |
| Novo Nordisk Inc | $19.57 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100470880 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.